Krajina: Spojené kráľovstvo
Jazyk: angličtina
Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)
Hexylresorcinol
Reckitt Benckiser Healthcare (UK) Ltd
R02AA12
Hexylresorcinol
2.4mg
Lozenge
Oromucosal
No Controlled Drug Status
Valid as a prescribable product
BNF: 12030300; GTIN: 5000158106185
OBJECT 1 STREPSILS EXTRA TRIPLE ACTION BLACKCURRANT LOZENGES Summary of Product Characteristics Updated 16-Jul-2015 | Reckitt Benckiser Healthcare (UK) Ltd 1. Name of the medicinal product Strepsils Extra Blackcurrant Lozenges Strepsils Extra Triple Action Blackcurrant Lozenges Strepsils Extra Strength Blackcurrant Lozenges 2. Qualitative and quantitative composition Each lozenge contains Hexylresorcinol 2.4mg For excipients see Section 6.1 3. Pharmaceutical form Lozenge A round purple lozenge 4. Clinical particulars 4.1 Therapeutic indications As an antiseptic and local anaesthetic for the relief of sore throat and its associated pain. 4.2 Posology and method of administration For oral administration. Adults, the elderly and children 6 years and over: One lozenge dissolved slowly in the mouth every three hours or as required. Do not take more than 12 lozenges in 24 hours. Not to be given to children under 6 years. 4.3 Contraindications Hypersensitivity to any of the ingredients. 4.4 Special warnings and precautions for use The label will convey: Keep out of the reach and sight of children. If symptoms persist consult your doctor. Not to be given to children under 6 years. This product is unsuitable in hereditary fructose intolerance, glucose-galactose malabsorption syndrome, or sucrose-isomaltase deficiency. 4.5 Interaction with other medicinal products and other forms of interaction None known. 4.6 Pregnancy and lactation There is lack of evidence of safety of the product in human pregnancy and in animals, but hexylresorcinol has been used widely in lozenges for many years without apparent ill consequence. However, as with all medicines, caution should be exercised during pregnancy and lactation. 4.7 Effects on ability to drive and use machines None known. 4.8 Undesirable effects None known. 4.9 Overdose Hexylresorcinol overdosage may cause minor gastrointestinal irritation. Treatment would be withdrawal of the product and symptomatic measures as appropriate. 5. Pharmacological properties 5.1 Pharmacodynamic pr Prečítajte si celý dokument